So they were wrong yet again. Or they lied in order to get people to take the vaccine. Either one.
Mild cases of COVID-19 leave people with long-term antibody protection against reinfection, according to a new study that challenges previous findings.
“Last fall, there were reports that antibodies wane quickly after infection with the virus that causes COVID-19, and mainstream media interpreted that to mean that immunity was not long-lived,” said study senior author Ali Ellebedy, an associate professor of pathology and immunology, medicine and molecular microbiology at Washington University School of Medicine in St. Louis.
“But that’s a misinterpretation of the data. It’s normal for antibody levels to go down after acute infection, but they don’t go down to zero; they plateau,” Ellebedy said in a university news release. “Here, we found antibody-producing cells in people 11 months after first symptoms. These cells will live and produce antibodies for the rest of people’s lives. That’s strong evidence for long-lasting immunity.”
- Insane Vid — Man Stream Admission he Killed His Ex-Girlfriend as he prepares to Kill Ex-Wife
- JAMA: Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US
- Aussie Police confirm use of controversial LRAD Weapon against Canberra protestors
- Sweden’s Lund University researcher faces prosecution for study that showed most rapes are committed by immigrants
- Politics over Science! AMA Recommends Removing Gender From Birth Certificates
- Something Really Strange (and Scary) Is Happening At Hospitals All Over America
- Not so fast. The Very Misleading Article By a Priest on Drugs And Abortion Testing
- Prince Andrew agrees to settlement in Jeffrey Epstein sex abuse case
- Blue’s Clues Transgender Propaganda
- The Chinese Communist Party is Still Buying Up American Land.